BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.54
+2.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 50.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.48x
- Price / sales
- 4.04x
- Price / cash flow
- -1.20x
Enterprise value
- Enterprise value
- -$248.9M
- EV / sales
- -4.07x
- EV / EBITDA
- 1.36x
- EV / EBIT
- 1.18x
- Market cap
- $247.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026